Invictus RG (Singapore)’s Core Laboratories CLB Stock Holding History

Invictus RG (Singapore)’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-675	Closed	-$129K	–	586
2013 Q4	$129K	Buy	+675	New	+$126K	0.09%	325

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Invictus RG (Singapore)'s CLB Position: Q1 2014 in Review

Invictus RG (Singapore) sold out of Core Laboratories (CLB) in Q1 2014, closing a stake of 675 shares — an estimated $129K sold.

Invictus RG (Singapore) first reported a position in CLB in Q4 2013 and held it in 1 quarter. The position peaked at $129K in Q4 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q1 2014.

Invictus RG (Singapore) reported no remaining Core Laboratories position as of Q1 2014 after selling out during the quarter.
Invictus RG (Singapore) sold 675 Core Laboratories shares in Q1 2014, an estimated $129K.
Invictus RG (Singapore) first reported a position in Core Laboratories in Q4 2013 and held it in 1 quarter.
Invictus RG (Singapore)'s Core Laboratories position peaked at $129K in Q4 2013.
346 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2014.

Based on Invictus RG (Singapore)'s 13F filing for Q1 2014, filed 14 May 2014.